Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE001142 |
ID: | TCMBANKHE001142 |
药用植物名: | 木菊 |
TCM_ID_id: | 3436 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN017427 | apiin | C26H28O14 | 564.49 | C1C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)CO)O)O)O)(CO)O | |
| TCMBANKIN026251 | matricin | C17H22O5 | 306.4 g/mol | CC1C2C(CC(=C3C=CC(C3C2OC1=O)(C)O)C)OC(=O)C | |
| TCMBANKIN027512 | matrine | .alpha.-Matrine; Matrene, (+)-; STOCK1N-36535; Matrine; BRN 0085851; (+)-Matrine; ZINC4196454; 519-02-8; Matridin-15-one (9CI); C10774; NSC146051; 5-24-02-00301 (Beilstein Handbook Reference); NSC 146051 | C15H24N2O | 248.36 | C1CC2C3CCCN4C3C(CCC4)CN2C(=O)C1 |
| TCMBANKIN032348 | Paucin | [6-[(5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-6-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate; [(2R,3S,4S,5R,6R)-6-[[(3aR,5R,5aS,6S,8aS,9aR)-5,8a-dimethyl-1-methylene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-6-yl]oxy]-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl acetate; [(2R,3S,4S,5R,6R)-6-[[(3aR,5R,5aS,6S,8aS,9aR)-5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-6-yl]oxy]-3,4,5-trihydroxy-oxan-2-yl]methyl ethanoate; paucin; [(2R,3S,4S,5R,6R)-6-[[(3aR,5R,5aS,6S,8aS,9aR)-5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-6-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate; acetic acid [(2R,3S,4S,5R,6R)-6-[[(3aR,5R,5aS,6S,8aS,9aR)-5,8a-dimethyl-1-methylene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-6-yl]oxy]-3,4,5-trihydroxy-2-tetrahydropyranyl]methyl ester; AC1NQKFM; Azuleno(6,5-b)furan-2,5-dione, 7-((6-O-acetyl-beta-D-glucopyranosyl)oxy)decahydro-4a,8-dimethyl-3-methylene-, (3aR-(3aalpha,4abeta,7alpha,7aalpha,8alpha,9aalpha))-; C09525; acetic acid [(2R,3S,4S,5R,6R)-6-[[(3aR,5R,5aS,6S,8aS,9aR)-2,8-diketo-5,8a-dimethyl-1-methylene-3a,4,5,5a,6,7,9,9a-octahydroazuleno[5,6-d]furan-6-yl]oxy]-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl ester; 26836-43-1 | C23H32O10 | 468.49 | CC1CC2C(CC3(C1C(CC3=O)OC4C(C(C(C(O4)COC(=O)C)O)O)O)C)C(=C)C(=O)O2 |
| TCMBANKIN037001 | alpha-Guaiene | (1S,4S,7R)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene; alpha-guaiene; α-guaiene; (1S,4S,7R)-7-isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene | C15H24 | 204.35 g/mol | CC1CCC(CC2=C1CCC2C)C(=C)C |
| TCMBANKIN040021 | farnesiferol a | 7-{[(1S,4AS,6R,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]METHOXY}CHROMEN-2-ONE; SCHEMBL12362728; 7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; 8YC9944MPJ; UNII-8YC9944MPJ; Farnesiferol A, >=85% (NMR); 511-33-1; DTXSID00199105; ZINC4081322; Farnesiferol A; Mogoltadin; NCGC00385155-01!7-[[(1S,4aS,6R,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methoxy]chromen-2-one; MolPort-002-525-707; CHEMBL1078138; AC1OF2BZ | C24H30O4 | 382.5 g/mol | CC1(C2CCC(=C)C(C2(CCC1O)C)COC3=CC4=C(C=C3)C=CC(=O)O4)C |
| TCMBANKIN041605 | Bisabolol oxide A | bisabolol oxide-a | 238.37 g/mol | ||
| TCMBANKIN046252 | 4,4alpha,5,6,7,8-hexahydro-4,4alpha-dimethyl-6-(1-methylethenyl)-2(3h)-naphthalene | C15H22O | 218.335 | ||
| TCMBANKIN058410 | Azulen | InChI=1/C10H8/c1-2-5-9-7-4-8-10(9)6-3-1/h1-8; 82R6M9MGLP; 275-51-4; AC1L1SM7; MFCD00003810; AZULENE, M.P. 99 C; ST5411971;azulene; ACMC-209gy0; Cyclopentacycloheptene; A97203_ALDRICH; FCH1115647; 37879_RIEDEL; ZINC1570209; CHEBI:31249; DB-047243; UNII-82R6M9MGLP; TR-012336; A0634; SC-47564; NSC 89248; Bicyclo(5.3.0)-deca-2,4,6,8,10-pentaene; Azulene (JAN); DTXSID2059770; AN-5880; CC-24235; Bicyclo(0.3.5)deca-1,3,5,7,9-pentaene; Bicyclo(5.3.0)-1,3,5,7,9-decapentaene; labotest-bb lt00007822; azulene radical cation; Azulene cation radical; C-30055; SR-01000944574-1; AKOS015840881; D09768; ANW-26230; LS-23565; CS-0006517; bicyclo(5.3.0)-deca-1,3,5,7,9-pentaene; SR-01000944574; CHEMBL3272628; EINECS 205-993-6; S14-1306; Bicyclo(5.3.0)decapentaene; MCULE-9439882903; Azulene, standard for GC, >=99.0% (GC); CUFNKYGDVFVPHO-UHFFFAOYSA-N; ST50411971; S14-2908; cyclopentacyclohepten; Azunamic; LS40101; Bicyclo[5.3.0]-1,5,7,9-decapentaene; A819116; J-016811; NSC-89248; Azusalen [as sodium sulfonate]; NSC89248; Azulene, analytical standard; C13392; SBB056611; PubChem6349; CTK1A3397; KB-47493; Bicyclo[5.3.0]-1,3,5,7,9-decapentaene; azulene; Bicyclo[5.3.0]decapentaene; CJ-24708; Azulekeep; 11650_FLUKA; Azulene, 99%; FT-0622537; API0001577; azulen; CL22917; AZULENE | C10H8 | 128.17 g/mol | C1=CC=C2C=CC=C2C=C1 |
| TCMBANKIN058562 | Casuarictin | AIDS-001510; 1(beta)-O-Galloylpedunculagin; C10212; .beta.-D-Glucopyranose, cyclic 2,3:4,6-bis[(1S)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate] 1-(3,4,5-trihydroxybenzoate); casuarictin; Sanguiin h 11; 79786-00-8; AC1Q78IK; beta-D-Glucopyranose, cyclic 2,3:4,6-bis(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), (2(S),4(S))-; 1(.beta.)-O-Galloylpedunculagin; AIDS001510; 1(beta)-o-galloylpedunculagin | C41H28O26 | 936.65 g/mol | C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O |
| TCMBANKIN059999 | beta-Chamigrene | C15H24 | 204.35 g/mol | CC1=CCC2(CC1)C(=C)CCCC2(C)C | |
| TCMBANKIN060768 | BUA | C4H8O2 | 88.11g/mol | CCCC(=O)O | |
| TCMBANKIN061663 | axillarin | 3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; axillarin ; DTXSID80199840; NCGC00168986-01; C10021; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; CHEBI:2941; DMQT; Axillarin; 3',4',5,7-tetrahydroxy-3,6-dimethoxy-flavone; MCULE-1507651933; MEGxp0_000118; CHEMBL487810; AC1NQYPJ; 5188-73-8; 3,6-Dimethoxy-5,7,3',4'-tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; BDBM50242286; 3,6-Dimethoxyquercetagetin; ACon1_000535; SCHEMBL1155670; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-chromen-4-one; Quercetagetin 3,6-dimethyl ether; NCGC00168986-02!2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; NP-000321; LMPK12112990; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one;ACon1_000535; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromone; 5188-73-8; 3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; Quercetagetin 3,6-dimethyl ether; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4-chromenone; Axillarin; C10021; 3,6-Dimethoxyquercetagetin; MEGxp0_000118; DMQT | C17H14O8 | 346.3 g/mol | COC1=C(C2=C(C=C1O)OC(=C(C2=O)OC)C3=CC(=C(C=C3)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab